These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16494797)

  • 1. [Risk factors of and mechanism for non-responsiveness to hepatitis B vaccination].
    Zhuang GH; Yan H; Wang XL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):157-60. PubMed ID: 16494797
    [No Abstract]   [Full Text] [Related]  

  • 2. [The causes for hyporeactiveness of vaccination against hepatitis B and the strategies to resolve the situations].
    Cheng SC; Lo CH
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):108-10. PubMed ID: 8354106
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B vaccination in persons with isolated hepatitis B core antibodies.
    Liesnard CA
    Clin Infect Dis; 1999 Apr; 28(4):932-3. PubMed ID: 10825079
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions.
    van den Berg R; van Hoogstraten I; van Agtmael M
    AIDS Rev; 2009; 11(3):157-64. PubMed ID: 19654857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
    Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules.
    Wilson JN; Nokes DJ; Medley GF; Shouval D
    Vaccine; 2007 May; 25(18):3705-12. PubMed ID: 17306427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination. Hepatitis B].
    Braun R; Kimmig P; Hassler D
    Dtsch Med Wochenschr; 2002 May; 127(20):1062. PubMed ID: 12051190
    [No Abstract]   [Full Text] [Related]  

  • 8. Repeated-measures models to evaluate a hepatitis B vaccination programme.
    Renard D; Bruckers L; Molenberghs G; Vellinga A; Van Damme P
    Stat Med; 2001 Mar; 20(6):951-63. PubMed ID: 11252015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine.
    Adwan K; Abu-Hasan N; Adwan G; Abu-Khater K
    East Mediterr Health J; 2005 May; 11(3):494-8. PubMed ID: 16602472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The vaccination of medical personnel as the most important link in the prevention of viral hepatitis B].
    Akimkin VG; Skvortsov SV; Samokhodskaia LM; Lytsar' BN; Kvasovka VV
    Voen Med Zh; 1997 Dec; 318(12):33-6, 94. PubMed ID: 9504012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
    Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence of antibody after hepatitis B vaccine and the question of boosters.
    Tabor E
    Hepatology; 2005 Apr; 41(4):940; author reply 941. PubMed ID: 15791611
    [No Abstract]   [Full Text] [Related]  

  • 13. Intradermal hepatitis B vaccination: five-year follow-up.
    Leonardi S; Barone P; Musumeci S
    Pediatr Infect Dis J; 1995 Aug; 14(8):716-7. PubMed ID: 8532435
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
    Lin HH; Liao HW; Lin SK; Wang LY
    Vaccine; 2008 Jun; 26(27-28):3414-20. PubMed ID: 18501999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups.
    Koene RP; Gotz HM; Van Den Hoek JA; Heijnen ML; Van Steenbergen JA; Kroes AC
    Epidemiol Infect; 2009 Apr; 137(4):495-503. PubMed ID: 18647436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More on the need for boosters 15 years after neonatal vaccination.
    Chan CY; Lee SD
    Hepatology; 2005 Apr; 41(4):940-1; author reply 941. PubMed ID: 15726538
    [No Abstract]   [Full Text] [Related]  

  • 17. No seroconversion after hepatitis B immunization.
    Cherian T; John TJ
    Indian Pediatr; 1997 Jun; 34(6):555-6. PubMed ID: 9357216
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
    Ungulkraiwit P; Jongjirawisan Y; Atamasirikul K; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):680-5. PubMed ID: 17883006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical efficacy and immunologic responses of hepatitis B vaccination in very-low-birth-weight infants.
    Yang YJ; Lin CH; Tai YT; Huang SC; Lin YJ
    Pediatr Infect Dis J; 2008 Aug; 27(8):768. PubMed ID: 18574432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.